In summary, TFEB hepatic gene transfer decreased detrimental activation of liver apoptosis and fibrosis which underlines the pathogenesis of neonatal hepatitis, cirrhosis and hepatocellular carcinoma in AAT deficiency (Rudnick & Perlmutter, 2005). This evidence concerns the gene TFEB and neonatal hemochromatosis.